Fortis Capital Advisors, LLC
Position in GALT — Galectin Therapeutics Inc
CIK 1959790
PRAIRIE VILLAGE, KS
Position in GALT
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$65,604
-$230,523 QoQ
Shares Held
14,139
-86.7% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#61
of 98 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GALT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Fortis Capital Advisors, LLC holds $9,162,478 across 7 Biotechnology names. GALT ranks #6 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
25,423 | $2,881,951 | |
| 2 | TGTX |
Tg Therapeutics, Inc.
|
50,719 | $2,786,501 | |
| 3 | MRNA |
Moderna, Inc.
|
29,428 | $2,060,842 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,368 | $1,176,256 | |
| 5 | KLRS |
Kalaris Therapeutics, Inc.
|
40,000 | $162,800 | |
| 6 | GALT |
Galectin Therapeutics Inc
This page
|
14,139 | $65,604 | |
| 7 | CMPX |
Compass Therapeutics, Inc.
|
13,025 | $28,524 |
All Filings in GALT
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $65,604 | 14,139 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $296,127 | 106,139 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $441,538 | 106,139 | Shares | Sole | 2026-01-27 | |
| No filing history on record for this holder in this stock. | ||||||